{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:31:43Z","timestamp":1789497103870,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015748","name":"Chinese Academy of Sciences, Shanghai Branch","doi-asserted-by":"publisher","award":["JCYJ-SHFY-2022-005"],"award-info":[{"award-number":["JCYJ-SHFY-2022-005"]}],"id":[{"id":"10.13039\/501100015748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000148","name":"Canadian Anesthesiologists' Society","doi-asserted-by":"publisher","award":["2026PVA0110"],"award-info":[{"award-number":["2026PVA0110"]}],"id":[{"id":"10.13039\/501100000148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000148","name":"Canadian Anesthesiologists' Society","doi-asserted-by":"publisher","award":["XDB1060000"],"award-info":[{"award-number":["XDB1060000"]}],"id":[{"id":"10.13039\/501100000148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0214800"],"award-info":[{"award-number":["2025ZD0214800"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32494764"],"award-info":[{"award-number":["32494764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22477130"],"award-info":[{"award-number":["22477130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22425704"],"award-info":[{"award-number":["22425704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82188101"],"award-info":[{"award-number":["82188101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012465","name":"Dalian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019958","name":"Shanghai Advanced Research Institute, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.celrep.2025.116897","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:53:32Z","timestamp":1769111612000},"page":"116897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A monoclonal antibody targeting the C-terminal of \u03b1-synuclein fibrils mitigates pathology in a Parkinson\u2019s disease model"],"prefix":"10.1016","volume":"45","author":[{"given":"Shuyi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houfang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouqiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Datao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-6672","authenticated-orcid":false,"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116897_bib1","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","article-title":"Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis","volume":"5","author":"Zhu","year":"2024","journal-title":"Lancet. Healthy Longev."},{"key":"10.1016\/j.celrep.2025.116897_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The Emerging Evidence of the Parkinson Pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.celrep.2025.116897_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.celrep.2025.116897_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116897_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116897_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116897_bib7","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1073\/pnas.1903049116","article-title":"Functional cooperation of \u03b1-synuclein and VAMP2 in synaptic vesicle recycling","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116897_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.97228.3","article-title":"N-acetylation of \u03b1-synuclein enhances synaptic vesicle clustering mediated by \u03b1-synuclein and lysophosphatidylcholine","volume":"13","author":"Wang","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.116897_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2025.116897_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116897_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","article-title":"Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration","volume":"7","author":"Wang","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.116897_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-023-06251-8","article-title":"Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization","volume":"14","author":"Lurette","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2025.116897_bib13","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"\u03b1-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116897_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-018-0537-x","article-title":"\u03b1-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons","volume":"6","author":"Froula","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2025.116897_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116897_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.celrep.2025.116897_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys","volume":"75","author":"Recasens","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116897_bib18","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.jmb.2019.07.001","article-title":"Structural Insights into \u03b1-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations","volume":"431","author":"Ni","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.celrep.2025.116897_bib19","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.str.2023.08.006","article-title":"Molecular rules governing the structural polymorphism of amyloid fibrils in neurodegenerative diseases","volume":"31","author":"Li","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.celrep.2025.116897_bib20","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1038\/s41467-021-25966-w","article-title":"The Hsc70 disaggregation machinery removes monomer units directly from \u03b1-synuclein fibril ends","volume":"12","author":"Schneider","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116897_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","article-title":"Human Hsp70 Disaggregase Reverses Parkinson's-Linked \u03b1-Synuclein Amyloid Fibrils","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.116897_bib22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1126\/science.adp3645","article-title":"Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson's disease","volume":"387","author":"Wu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116897_bib23","article-title":"Mechanistic basis for receptor-mediated pathological \u03b1-synuclein fibril cell-to-cell transmission in Parkinson's disease","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116897_bib24","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1021\/jacs.2c10854","article-title":"Conformational Dynamics of an \u03b1-Synuclein Fibril upon Receptor Binding Revealed by Insensitive Nuclei Enhanced by Polarization Transfer-Based Solid-State Nuclear Magnetic Resonance and Cryo-Electron Microscopy","volume":"145","author":"Zhang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.celrep.2025.116897_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah3374","article-title":"Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116897_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111401","article-title":"Interaction of RAGE with \u03b1-synuclein fibrils mediates inflammatory response of microglia","volume":"40","author":"Long","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116897_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41422-024-01022-2","article-title":"\u03b1-Synuclein amyloid fibril directly binds to LC3B and suppresses SQSTM1\/p62-mediated selective autophagy","volume":"35","author":"Xu","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2025.116897_bib28","doi-asserted-by":"crossref","first-page":"28282","DOI":"10.1021\/jacs.4c08869","article-title":"Inhibitor Development for \u03b1-Synuclein Fibril's Disordered Region to Alleviate Parkinson's Disease Pathology","volume":"146","author":"Zhang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.celrep.2025.116897_bib29","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1038\/s41467-025-62755-1","article-title":"Design of Ig-like binders targeting \u03b1-synuclein fibril for mitigating its pathological activities","volume":"16","author":"Zeng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116897_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-3-19","article-title":"In vivo silencing of alpha-synuclein using naked siRNA","volume":"3","author":"Lewis","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2025.116897_bib31","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.celrep.2025.116897_bib32","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/mds.29170","article-title":"Phase 1\/1b Studies of UCB0599, an Oral Inhibitor of \u03b1-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease","volume":"37","author":"Smit","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.celrep.2025.116897_bib33","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/brain\/aww238","article-title":"A de novo compound targeting \u03b1-synuclein improves deficits in models of Parkinson's disease","volume":"139","author":"Wrasidlo","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2025.116897_bib34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2025.116897_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag2210","article-title":"Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease","volume":"8","author":"Ghosh","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116897_bib36","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","article-title":"c-Abl phosphorylates \u03b1-synuclein and regulates its degradation: implication for \u03b1-synuclein clearance and contribution to the pathogenesis of Parkinson's disease","volume":"23","author":"Mahul-Mellier","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2025.116897_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105281","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease","volume":"108","author":"Walsh","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.celrep.2025.116897_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00415-024-12770-x","article-title":"An update on immune-based alpha-synuclein trials in Parkinson\u2019s disease","volume":"272","author":"Alfaidi","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.celrep.2025.116897_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2013.01.013","article-title":"Immunotherapy for neurodegenerative diseases: focus on \u03b1-synucleinopathies","volume":"138","author":"Valera","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.celrep.2025.116897_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nbd.2018.10.016","article-title":"Development of an aggregate-selective, human-derived \u03b1-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models","volume":"124","author":"Weihofen","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.celrep.2025.116897_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104582","article-title":"Preclinical development of a high affinity \u03b1-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular \u03b1-synuclein and attenuate \u03b1-synuclein spreading in vivo","volume":"132","author":"Schofield","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.celrep.2025.116897_bib42","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1994690","article-title":"Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies","volume":"13","author":"Fjord-Larsen","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2025.116897_bib43","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/mds.29784","article-title":"Randomized Phase I Trial of the \u03b1-Synuclein Antibody Lu AF82422","volume":"39","author":"Buur","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.celrep.2025.116897_bib44","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/mds.29016","article-title":"A Randomized First-in-Human Study With UB-312, a UBITh\u00ae \u03b1-Synuclein Peptide Vaccine","volume":"37","author":"Yu","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.celrep.2025.116897_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.705407","article-title":"A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data","volume":"12","author":"Pagano","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.celrep.2025.116897_bib46","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116897_bib47","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1038\/s41591-024-03270-6","article-title":"Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116897_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of Prasinezumab in Early-Stage Parkinson's Disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116897_bib49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2025.116897_bib50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116897_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012435118","article-title":"Wild-type \u03b1-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding","volume":"118","author":"Long","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116897_bib52","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2025.116897_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2025.116897_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.celrep.2025.116897_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116897_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116897_bib57","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1038\/s41467-022-31457-3","article-title":"Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space","volume":"13","author":"Makowski","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116897_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.adk8946","article-title":"Unsupervised evolution of protein and antibody complexes with a structure-informed language model","volume":"385","author":"Shanker","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116897_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.116897_bib60","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2025.116897_bib79","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.celrep.2025.116897_bib61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","article-title":"CTFFIND4: Fast and accurate defocus estimation from electron micrographs","volume":"192","author":"Rohou","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2025.116897_bib62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1107\/S2059798319016577","article-title":"Amyloid structure determination in RELION-3.1","volume":"76","author":"Scheres","year":"2020","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.celrep.2025.116897_bib63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2025.116897_bib80","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116897_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00197809","article-title":"NMRPipe: a multidimensional spectral processing system based on UNIX pipes","volume":"6","author":"Delaglio","year":"1995","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.celrep.2025.116897_bib65","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/bioinformatics\/btu830","article-title":"NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy","volume":"31","author":"Lee","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2025.116897_bib66","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2025.116897_bib67","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-024-49016-3","article-title":"Aplp1 interacts with Lag3 to facilitate transmission of pathologic \u03b1-synuclein","volume":"15","author":"Mao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116897_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106882","article-title":"Kinetic titration series with biolayer interferometry","volume":"9","author":"Frenzel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.116897_bib69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41596-024-01079-8","article-title":"Biolayer interferometry for measuring the kinetics of protein-protein interactions and nanobody binding","volume":"20","author":"Bates","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2025.116897_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019338","article-title":"Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease","volume":"6","author":"Masliah","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.116897_bib71","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41589-023-01370-x","article-title":"Structural mechanism for specific binding of chemical compounds to amyloid fibrils","volume":"19","author":"Tao","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2025.116897_bib72","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2025.116897_bib73","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41592-019-0580-y","article-title":"Real-time cryo-electron microscopy data preprocessing with Warp","volume":"16","author":"Tegunov","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.116897_bib74","article-title":"AreTomo: An integrated software package for automated marker-free, motion-corrected cryo-electron tomographic alignment and reconstruction","volume":"6","author":"Zheng","year":"2022","journal-title":"J. Struct. Biol. X"},{"key":"10.1016\/j.celrep.2025.116897_bib75","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1038\/s41467-022-33957-8","article-title":"Isotropic reconstruction for electron tomography with deep learning","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116897_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001318","article-title":"Step-by-step guide to efficient subtomogram averaging of virus-like particles with Dynamo","volume":"19","author":"Scaramuzza","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2025.116897_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jsb.2011.12.003","article-title":"PyTom: a python-based toolbox for localization of macromolecules in cryo-electron tomograms and subtomogram analysis","volume":"178","author":"Hrabe","year":"2012","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2025.116897_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725016699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725016699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:06:38Z","timestamp":1777093598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725016699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2211124725016699"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116897","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A monoclonal antibody targeting the C-terminal of \u03b1-synuclein fibrils mitigates pathology in a Parkinson\u2019s disease model","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116897"}}